Leadership Overview
ZOLL has 8 executives leading key functions including strategy, technology, operations, finance, and product management.
Driven by a commitment to improving patient outcomes, ZOLL is dedicated to developing innovative technologies for cardiopulmonary and respiratory conditions, impacting critical care globally.
Driven by a commitment to improving patient outcomes, ZOLL is dedicated to developing innovative technologies for cardiopulmonary and respiratory conditions, impacting critical care globally.
Leadership Roles at ZOLL
Eric Knudsen - Chief Executive Officer
Eric Knudsen, the Chief Executive Officer at ZOLL, directs the company's overall strategic vision and operational execution. Knudsen guides the organization's expansion in developing innovative technologies for diagnosing and treating cardiopulmonary and respiratory conditions. This leadership involves ensuring ZOLL's comprehensive range of medical devices, software solutions, and services effectively serve healthcare providers worldwide. Knudsen oversees the integration of advanced life support equipment, automated external defibrillators, and monitoring systems, all designed to enhance patient outcomes in critical care. The Chief Executive Officer's role encompasses driving market leadership and fostering a culture of continuous innovation across ZOLL's global operations in North America, Europe, and Asia. By focusing on medical technology advancements, Knudsen ensures the company maintains its strong position within the healthcare sector. This executive's strategic direction is paramount to ZOLL's mission of improving patient care through cutting-edge solutions. Eric Knudsen's leadership ensures alignment with the company's core objectives.
Walter Hall - Vice President Finance and Admin and Chief Financial Officer
Walter Hall, the Vice President Finance and Admin and Chief Financial Officer at ZOLL, directs the company's financial strategy, resource allocation, and administrative operations. Hall oversees the fiscal health of the organization, ensuring robust financial planning and management to support ZOLL's development of innovative medical technologies for cardiopulmonary and respiratory conditions. This critical role involves managing budgets, financial reporting, and investment strategies for advanced life support equipment, automated external defibrillators, and monitoring systems. The Vice President Finance and Admin and Chief Financial Officer's responsibilities include optimizing administrative processes to enhance operational efficiency across global markets. Walter Hall provides essential financial oversight that underpins ZOLL's commitment to improving patient outcomes in critical care. This executive's financial acumen is vital for sustaining the company's growth and innovation initiatives in North America, Europe, and Asia. Walter Hall's leadership ensures financial stability and strategic resource deployment.
Osnat Gat - Chief Operating Officer (Israel)
Osnat Gat, the Chief Operating Officer (Israel) at ZOLL, directs operational strategies and execution within the Israeli region, contributing to the company's global manufacturing and service delivery. Gat oversees the production and deployment of ZOLL's innovative medical devices, ensuring adherence to stringent quality standards for cardiopulmonary and respiratory condition treatments. This leadership role involves optimizing supply chain logistics and manufacturing processes for advanced life support equipment and automated external defibrillators. The Chief Operating Officer (Israel)'s responsibilities extend to managing local teams and resources to support the company's mission of improving patient outcomes in critical care. Osnat Gat ensures seamless integration of regional operations with ZOLL's broader international framework, supporting healthcare providers across various global markets. This executive's operational acumen is vital for maintaining efficiency and driving growth in key markets. Osnat Gat's focus on operational excellence supports ZOLL's commitment to medical technology innovation.
Michael Blastick - President, Zoll Cardiac Management Solutions
Michael Blastick, the President, Zoll Cardiac Management Solutions at ZOLL, leads the strategic direction and operational execution for the company's cardiac management technologies. Blastick drives the development and market penetration of solutions designed to diagnose and treat cardiac conditions, enhancing patient care pathways. This leadership role involves overseeing product innovation, sales, and service delivery for advanced cardiac monitoring systems and related software. The President, Zoll Cardiac Management Solutions' focus is on ensuring these technologies effectively improve patient outcomes in critical care settings. Michael Blastick collaborates with cross-functional teams to integrate these specialized solutions into ZOLL's broader portfolio, supporting healthcare providers globally. This executive's expertise is crucial for advancing ZOLL's position in the cardiac care market. Michael Blastick's leadership ensures the continued success and evolution of cardiac management offerings.
Elijah White - Executive Officer President, ZOLL Acute Care Technology
Elijah White, the Executive Officer President, ZOLL Acute Care Technology at ZOLL, directs the strategic vision and operational management for the company's acute care technology division. White spearheads the innovation and deployment of critical medical devices and software solutions aimed at improving patient outcomes in emergency and critical care settings. This leadership encompasses overseeing the development of advanced life support equipment, automated external defibrillators, and comprehensive monitoring systems. The Executive Officer President, ZOLL Acute Care Technology's mandate is to ensure these technologies effectively address cardiopulmonary and respiratory conditions for healthcare providers worldwide. Elijah White fosters collaboration across departments to enhance product efficacy and expand market reach in North America, Europe, and Asia. This executive's focus on acute care advancements is central to ZOLL's mission. Elijah White's leadership drives excellence in critical care technology.
Suzy Drees - President
Suzy Drees, the President at ZOLL, drives strategic initiatives and operational oversight across key business segments, contributing to the company's overall growth and market leadership. Drees focuses on enhancing ZOLL's comprehensive range of medical devices, software solutions, and services that diagnose and treat cardiopulmonary and respiratory conditions. This leadership role involves guiding teams to ensure the effective deployment of advanced life support equipment, automated external defibrillators, and monitoring systems designed to improve patient outcomes in critical care. The President's responsibilities include fostering strong relationships with healthcare providers globally and championing innovation within the medical technology sector. Suzy Drees ensures alignment with ZOLL's mission to advance patient care through cutting-edge solutions. This executive's broad operational influence supports ZOLL's presence and impact across North America, Europe, and Asia. Suzy Drees' leadership is integral to ZOLL's continued success.
Koby Sheffy - Chief Technology Officer
Koby Sheffy, the Chief Technology Officer at ZOLL, architects the company's technological roadmap and innovation pipeline. Sheffy drives the development of cutting-edge solutions that address cardiopulmonary and respiratory conditions, ensuring ZOLL remains at the forefront of medical device manufacturing. This role involves overseeing research and development initiatives for advanced life support equipment, automated external defibrillators, and sophisticated monitoring systems. The Chief Technology Officer's focus is on translating complex technological concepts into practical applications that improve patient outcomes in critical care settings. Sheffy collaborates with cross-functional teams to integrate new technologies into ZOLL's product portfolio, supporting global healthcare providers. Koby Sheffy's technical leadership is crucial for maintaining the company's competitive edge and expanding its reach across North America, Europe, and Asia. The Chief Technology Officer ensures that ZOLL's software solutions and hardware innovations meet the highest standards of efficacy and reliability. This executive's vision shapes the future of ZOLL's technological offerings.
Uriel Weinstein - General Manager and Chief Technology Officer
Uriel Weinstein, the General Manager and Chief Technology Officer at ZOLL, spearheads technological advancements and oversees general management functions, driving innovation in cardiopulmonary and respiratory care solutions. Weinstein leads the strategic development and implementation of new medical devices and software, ensuring ZOLL's products meet evolving healthcare needs globally. This dual role involves managing key operational aspects while championing the integration of cutting-edge technologies for advanced life support equipment and automated external defibrillators. The General Manager and Chief Technology Officer's purview includes fostering a culture of innovation and ensuring the effective deployment of monitoring systems to improve patient outcomes in critical care. Uriel Weinstein's leadership ensures that ZOLL's technological initiatives align with its mission to provide superior medical solutions. This executive's comprehensive oversight supports ZOLL's presence in North America, Europe, and Asia. Uriel Weinstein's contributions are central to ZOLL's technological leadership.
Explore Leadership Teams in Manufacturing
Founded in 2001, Aeroflow Health is a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services. With a steadfast commitment to empowering patients and improving their understanding of benefits, Aeroflow Health provides a curated experience for every individual and group. Offering a comprehensive portfolio of high-quality products, Aeroflow Health is dedicated to enhancing health outcomes and closing care gaps, ensuring that patients receive the care they deserve. Aeroflow's commitment to accessible healthcare has resulted in partnerships.
Company Leadership
LB
CW
JW
Orthofix is a global medical technology company based in Lewisville, Texas, focused on developing solutions for the treatment of musculoskeletal conditions. The company provides a broad range of medical technologies designed to improve patient outcomes, including spinal hardware, bone growth therapies, specialized limb reconstruction solutions, biologics, and enabling technologies, serving patients worldwide.
Company Leadership MC
BM
Dental Implant & Denture Laboratory in Staten Island, New York At our laboratory, we work with you and your patients as a team. Let us help you successfully complete your dental implant cases. Our dental consultants discuss the specifics of any case with you. Ask us about our complete denture services today. We make traditional dentures and partials, and we offer additional dentures at additional cost. With a strong commitment to the dental professional, we offer several dental seminars. We want to keep our customers educated on the current trends and technology. Contact us today in Staten Island, New York , when you need services from a dental implant and denture laboratory you can trust. With more than 40 years of experience, the staff at our dental implant and denture laboratory in Staten Island, New York, is a select group of technicians experienced in implant dentistry. Since 1985, Specialized Dental Implants & Restoration has been committed to your success. We offer a large variety of options and we have the knowledge and experience to achieve long-term predictable results. We are committed to returning your work on a timely schedule, and we accept most leading major credit cards for your convenience. Check back frequently for more information on how we can benefit your practice by providing quality restorations that add value to your service.
Company Leadership LB
DS
RR
Quality Needles Pvt. Ltd. specializes in the manufacture of surgical suture needles, covering a vast range of over 41984 different SKUs for various surgical procedures. Founded in 1984, the company has established itself as one of the world's leading needle producers, with an impressive annual production exceeding 400 million needles. Their offerings include channel type needles, general surgery needles, and specialty needles, such as sternotomy needles and temporary cardiac pacing leads. The intended clients primarily consist of surgical facilities and medical professionals requiring high-quality surgical instrumentation.
Company Leadership AB
MA
SD
PG
Frequently Asked Questions Regarding ZOLL Top Executives and Leadership Team
